Please read the Patient Information Leaflet (PIL) before taking SOTYKTU® (deucravacitinib).

Use this page to explore and download your Psoriasis Discussion Guide. It will only take you a few minutes to complete and will help you to tell your dermatology care team what is really important to you. You should tell your dermatology care team how you really feel and how your psoriasis makes you feel, so you develop the best possible treatment and support plan.

Step 1

Preparation = confidence

Prepare what you’d really like to say in advance so you can have a tailored conversation relevant to YOUR situation.

Step 2

Set goals

Successful psoriasis management is not all about numbers. Agree clear life goals with your dermatology care team and use these to track how your treatment is helping.

Step 3

Get the support you need

You won’t know unless you ask. Have the confidence to ask about things like getting access to professional emotional support when you need it.

Download the psoriasis discussion guide

This discussion guide can be downloaded to your computer or device as a PDF. Neither Bristol Myers Squibb nor any other company have access to any of the data you include in this guide.

Please always download the latest version of the discussion guide before speaking with your healthcare team.

Reporting of side effects

If you get any side effects, talk to your doctor, nurse, or pharmacist. This includes any possible
side effects not listed in your patient information leaflet or on this website.

V This medicinal product is subject to additional monitoring. This will allow quick identification of new
safety information. You can help by reporting any side effects you may get.

See www.mhra.gov.uk/yellowcard for how to report side effects or search for MHRA Yellow Card in the Google Play or Apple App Store.
Side effects should also be reported to Bristol-Myers Squibb Medical Information on 0800 731 1736 or medical.information@bms.com